Molecular Detection and Characterization of the Staphylococcus epidermidis and Staphylococcus haemolyticus Isolated from Hospitalized Patients and Healthcare Workers in Iran

Table 2

The antibiotic resistance profile of S. epidermidis and S. haemolyticus isolated from HPs and HCWs.

Antibiotics	HPs & HCWs		value	HPs & HCWs		value
	S. epidermidis ()	S. haemolyticus; ()		HPs	HCWs
Cefoxitin	50 (80.6)	17 (89.5)	0.37	46 (83.6)	21 (80.8)	0.75
Ciprofloxacin	28 (45.2)	15 (78.9)	0.01	31 (56.4)	12 (46.2)	0.39
Gentamicin	43 (69.4)	9 (47.4)	0.80	37 (67.3)	15 (57.7)	0.40
Chloramphenicol	19 (30.6)	9 (47.4)	0.18	25 (45.5)	3 (11.5)	0.03
Erythromycin	34 (54.8)	11 (57.9)	0.81	36 (65.5)	9 (34.6)	0.09
Clindamycin	28 (45.2)	12 (63.2)	0.17	32 (58.2)	8 (30.8)	0.02
Trimethoprim-sulfamethoxazole	52 (83.9)	14 (73.7)	0.31	52 (94.5)	14 (53.8)	<0.001
Linezolid	0	0	—	0	0	—
MDR	45 (72.6)	15 (78.9)	0.58	44 (80)	16 (61.5)	0.07

SXT: trimethoprim-sulfamethoxazole; MDR: multidrug resistance. Statistically significant.